scholarly journals Introduction to the United Kingdom National Multidisciplinary Guidelines for Head and Neck Cancer

2016 ◽  
Vol 130 (S2) ◽  
pp. S3-S4 ◽  
Author(s):  
V Paleri ◽  
N Roland

AbstractThis is the 5th edition of the UK Multi-Disciplinary Guidelines for Head and Neck Cancer, endorsed by seven national specialty associations involved in head and neck cancer care. Our aim is to provide a document can be used as a ready reference for multidisciplinary teams and a concise easy read for trainees. All evidence based recommendations in this edition are indicated by ‘(R)’ and where the multidisciplinary team of authors consider a recommendation to be based on clinical experience, it is denoted by ‘(G)’ as a good practice point.

2020 ◽  
Vol 46 (1) ◽  
pp. 284-294
Author(s):  
◽  
Matthew Ellis ◽  
George Garas ◽  
John Hardman ◽  
Maha Khan ◽  
...  

Author(s):  
Muralidhar Beeram ◽  
Andrew Kennedy ◽  
Nathan Hales

Complex, coordinated, and collaborative care of patients with head and neck cancer can be challenging yet amazingly rewarding and successful. The high symptom burden across multiple functional domains in patients with head and neck cancer, even in early stages of disease, mandates a multidisciplinary team approach that harnesses the combined contributions of physicians and ancillary providers to drive greater patient-centered care, addressing factors that heavily influence morbidity, mortality, and quality of life. Well-organized community-based multidisciplinary teams fulfill this unmet need and benefit patients with conveniently located comprehensive services that are typically found in large academic centers. Equivalent, if not superior, outcomes can be achieved in a unified community-based multidisciplinary team with shared patient-centered and outcomes-based goals. However, implementing true multidisciplinary team care in today’s complex health care environment is fraught with challenges and pitfalls. So how have some community-based practices managed to create safe and efficient programs with successful outcomes? The purpose of this review is to discuss barriers to reaching this success and emphasize practical solutions to such challenges.


2016 ◽  
Vol 130 (S2) ◽  
pp. S5-S8 ◽  
Author(s):  
F Stafford ◽  
K Ah-See ◽  
M Fardy ◽  
K Fell

AbstractThis is the official guideline endorsed by the surgical specialty associations involved in the care of head and neck cancer patients in the UK. This paper summarises the current state of play in the organisation and provision of head and neck cancer surgical services in the UK.


2020 ◽  
Vol 34 ◽  
Author(s):  
Claudiane MAHL ◽  
Luís Ricardo Santos de MELO ◽  
Maria Helena Andrade ALMEIDA ◽  
Catarina Sampaio CARVALHO ◽  
Lois Lene Silva SANTOS ◽  
...  

2013 ◽  
Vol 13 (6) ◽  
pp. 834-843 ◽  
Author(s):  
Francesco Perri ◽  
Paolo Muto ◽  
Corrado Aversa ◽  
Antonio Daponte ◽  
Giuseppina Vittoria ◽  
...  

2013 ◽  
Vol 999 (999) ◽  
pp. 1-7 ◽  
Author(s):  
Francesco Perri ◽  
Paolo Muto ◽  
Corrado Aversa ◽  
Antonio Daponte ◽  
Giuseppina Della Vittoria ◽  
...  

2021 ◽  
pp. 030089162110079
Author(s):  
Marta Tagliabue ◽  
Beth Russell ◽  
Charlotte Moss ◽  
Rita De Berardinis ◽  
Francesco Chu ◽  
...  

Objective: To describe the approach and outcomes from two cancer centres in Southern and Northern Europe during the first wave of coronavirus disease 2019 (COVID-19) of patients with head and neck cancer (HNC). Methods: Data collection was performed on a retrospective cohort of patients surgically treated for primary HNC between March and May 2020, using data from two tertiary hospitals: the European Institute of Oncology (Milan) and Guy’s & St Thomas’ NHS Foundation Trust (London). Results: We included 77 patients with HNC. More patients with COVID-19 were taking angiotensin-converting enzyme (ACE) inhibitors and had Clavien-Dindo Classification grade I compared to negative patients, respectively (60% vs 22% [ p = 0.058] and 40% vs 8% [ p = 0.025]). Multivariate logistic regression analyses confirmed our data ( p = 0.05 and 0.03, respectively). Sex and age were statistically significantly different ( p = 0.05 and <0.001 respectively), showing more male patients (75% vs 53.66%, respectively) and more elderly patients in Italy than in the United Kingdom (patients aged >63 years: 69.44% vs 29.27%). Conclusions: This study presents a large cohort of patients with HNC with nasopharyngeal swab during the first peak of the COVID-19 pandemic in Europe. Patients with HNC with COVID-19 appeared more likely to develop postsurgical complications and to be taking ACE inhibitors. The preventive measures adopted guaranteed the continuation of therapeutic surgical intervention.


2011 ◽  
Vol 104 (8) ◽  
pp. 1246-1248 ◽  
Author(s):  
P L Friedland ◽  
B Bozic ◽  
J Dewar ◽  
R Kuan ◽  
C Meyer ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document